These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12529435)

  • 1. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
    Chellaiah MA; Kizer N; Biswas R; Alvarez U; Strauss-Schoenberger J; Rifas L; Rittling SR; Denhardt DT; Hruska KA
    Mol Biol Cell; 2003 Jan; 14(1):173-89. PubMed ID: 12529435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts.
    Chellaiah MA; Biswas RS; Rittling SR; Denhardt DT; Hruska KA
    J Biol Chem; 2003 Aug; 278(31):29086-97. PubMed ID: 12730217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.
    Chellaiah MA; Hruska KA
    Calcif Tissue Int; 2003 Mar; 72(3):197-205. PubMed ID: 12469249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling.
    Kim JM; Lee K; Jeong D
    BMB Rep; 2018 May; 51(5):230-235. PubMed ID: 29301608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
    In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
    Tani-Ishii N; Tsunoda A; Umemoto T
    J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclasts secrete osteopontin into resorption lacunae during bone resorption.
    Luukkonen J; Hilli M; Nakamura M; Ritamo I; Valmu L; Kauppinen K; Tuukkanen J; Lehenkari P
    Histochem Cell Biol; 2019 Jun; 151(6):475-487. PubMed ID: 30637455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.
    Faccio R; Grano M; Colucci S; Villa A; Giannelli G; Quaranta V; Zallone A
    J Cell Sci; 2002 Jul; 115(Pt 14):2919-29. PubMed ID: 12082152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.
    Ek-Rylander B; Andersson G
    Exp Cell Res; 2010 Feb; 316(3):443-51. PubMed ID: 19854170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function.
    Reinholt FP; Hultenby K; Heinegård D; Marks SC; Norgård M; Anderson G
    Exp Cell Res; 1999 Sep; 251(2):477-91. PubMed ID: 10471332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength.
    Chellaiah M; Kizer N; Silva M; Alvarez U; Kwiatkowski D; Hruska KA
    J Cell Biol; 2000 Feb; 148(4):665-78. PubMed ID: 10684249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro.
    Aitken CJ; Hodge JM; Nicholson GC
    J Cell Biochem; 2004 Nov; 93(5):896-903. PubMed ID: 15389974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.
    Rittling SR; Matsumoto HN; McKee MD; Nanci A; An XR; Novick KE; Kowalski AJ; Noda M; Denhardt DT
    J Bone Miner Res; 1998 Jul; 13(7):1101-11. PubMed ID: 9661074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption.
    Biswas RS; Baker D; Hruska KA; Chellaiah MA
    BMC Cell Biol; 2004 May; 5():19. PubMed ID: 15142256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis.
    Ohshima S; Kobayashi H; Yamaguchi N; Nishioka K; Umeshita-Sasai M; Mima T; Nomura S; Kon S; Inobe M; Uede T; Saeki Y
    Arthritis Rheum; 2002 Apr; 46(4):1094-101. PubMed ID: 11953989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and temporal distribution of CD44 and osteopontin in fracture callus.
    Yamazaki M; Nakajima F; Ogasawara A; Moriya H; Majeska RJ; Einhorn TA
    J Bone Joint Surg Br; 1999 May; 81(3):508-15. PubMed ID: 10872376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.
    Yao Z; Xing L; Qin C; Schwarz EM; Boyce BF
    J Biol Chem; 2008 Apr; 283(15):9917-24. PubMed ID: 18250170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro.
    Boudiffa M; Wade-Gueye NM; Guignandon A; Vanden-Bossche A; Sabido O; Aubin JE; Jurdic P; Vico L; Lafage-Proust MH; Malaval L
    J Bone Miner Res; 2010 Dec; 25(12):2669-79. PubMed ID: 20812227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.